Medicament for treatment of neurodegenerative diseases

Details for Australian Patent Application No. 2003242124 (hide)

Owner INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC.

Inventors Muto, Susumu; Itai, Akiko

Agent Collison & Co of **** Street Adelaide SA 5000 Australia

Pub. Number AU-A-2003242124

PCT Number PCT/JP03/07128

PCT Pub. Number WO2003/103657

Priority 2002-169640 11.06.02 JP

Filing date 5 June 2003

Wipo publication date 22 December 2003

International Classifications

A61K 031/167 - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 031/4418 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/4453 - only substituted in position 1, e.g. propipocaine, diperodon

A61K 031/451 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 031/454

A61K 031/47 - Quinolines

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 031/4965 - Non-condensed pyrazines

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 031/505 - Pyrimidines

A61K 031/5375 - 1,4-Oxazines, e.g. morpholine

A61K 031/5377

A61K 031/695 - Silicon compounds

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 031/18 - Sulfonamides

A61K 031/235

A61K 031/277

A61K 031/381 - having five-membered rings

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/402 - 1-aryl-substituted, e.g. piretanide

A61K 031/404

A61K 031/415 - 1,2-Diazoles

A61K 031/4164 - 1,3-Diazoles

A61K 031/421 - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 031/422 - not condensed and containing further heterocyclic rings

A61K 031/426 - 1,3-Thiazoles

A61K 031/427 - not condensed and containing further heterocyclic rings

A61K 031/433 - Thiadiazoles

A61K 031/437

A61K 031/44 - Non-condensed pyridines

A61K 031/4406 - only substituted in position 3, e.g. zimeldine

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 2002-169640 11.06.02 JP

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003242124

13 January 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Medicament for treatment of neurodegenerative diseases

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003242125-STEREO-LIGHT DOUBLE-JUNCTION PHOTOVOLATIC CELL

2003242123-THE COMMUNITY NETWORK SYSTEM WITH BROADBAND INTEGRATED SERVICES